In total , 49 patients who received 2 EMD640744 injections with available baseline - and 1 post-vaccination samples [ immunologic-diagnostic ( ID ) - intention-to-treat ] were analyzed by ELISpot - and peptide/MHC-multimer staining , revealing vaccine-activated peptide-specific T-cell responses in 31 patients ( 63 % ) .